Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


Orphan Drugs Research and Commercialization

08 May 2013 - 10 May 2013 - Boston, MA, USA



Bookmark and Share


GTC is proud to announce its inaugural Orphan Drugs Research and Commercialization Conference at a crucial time in the rare disease space. With new therapies emerging in rare disease treatment and exciting partnerships being forged between big pharma and smaller niche companies, it is clear that the field of rare disease and orphan drug is growing. Rather than merely reciting the challenges of orphan drug development, it is time all stakeholders in the community come together to find innovative solutions in order to better serve rare disease patients.

This meeting connects industry, academia, regulators, and patient groups to dialogue about strategies to improve orphan drug research, pricing, reimbursement, access, and other key topics. 

The Orphan Drugs Research and Commercialization Conference is one of five parallel tracks to the 2nd Novel Technologies in Drug Discovery Summit on May 8 - 10,  2013 in Boston, MA. 

Tentative Sessions Include:

Pre-Conference Workshop: Developing an Effective Pricing and Reimbursement Strategy

Novel Therapeutics in Rare Diseases

Designing Effective Clinical Trials Case Studies in the Preclinical and Clinical Space

Partnering in Rare Diseases

Commercialization of Orphan Drugs

Panel Discussion: Regulatory in Orphan Drug Development

We look forward to seeing you at the conference!

 



Further information
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
NCI Collaborates with Multiple Myeloma Research Foundation
NCI collaborates with MMRF to incorporate genomic and clinical data into NCI Genomic Data Commons database.
New Imaging Technique in Alzheimer’s Disease
Study confirms new imaging technique corresponds a higher degree of actual brain changes.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Antibiotic Resistance Can Occur Naturally in Soil Bacteria
Scientists have found natural anti-biotic resistant bacteria in soils with little to no human exposure.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!